IP Library Granted Patent US 8,703,177
Granted Patent B2
US 8,703,177 · App. 13/590,094 · Granted Apr 22, 2014

Abuse-resistant mucoadhesive devices for delivery of buprenorphine

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,703,177
App. No.
13/590,094
Granted
Apr 22, 2014
Kind
B2
Abstract

The present invention provides abuse deterrent mucoadhesive devices for delivery of buprenorphine. Each device comprises a mucoadhesive layer and a backing layer, and the pH in each layer is selected, such that absorption of buprenorphine is maximized.

Claims (12)

1. An abuse deterrent mucoadhesive device for use in managing pain or opioid dependence, the device comprising:

a mucoadhesive layer comprising between about 0.075 and about 12 mg of buprenorphine buffered to a pH of between about 4.0 and about 6.0; and

a backing layer comprising between about 0.0125 and about 2 mg of naloxone buffered to a pH between about 4.0 and about 4.8,

wherein the pH of the mucoadhesive layer and the pH of the backing layer are different,

wherein the mucoadhesive layer and the backing layer comprise different combinations of polymers but each layer comprises at least one water-erodible polymer selected from the group consisting of: cellulosic polymers, olefinic polymers, polyethers and polyalcohols, and

wherein following transmucosal administration excessive exposure to buprenorphine is avoided while the abuse-deterrent effect of naloxone is retained.

2. The device according to claim 1 , wherein the w/w ratio of buprenorphine to naloxone present in the device is between 1:1 and 10:1.

3. The device according to claim 2 , wherein the w/w ratio of buprenorphine to naloxone present in the device is 6:1.

4. The device according to claim 3 , wherein the mucoadhesive layer is buffered to a pH of between about 4.50 and about 5.50 and the wherein the backing layer is buffered to a pH of between about 4.10 and about 4.4.

5. The device according to claim 4 , wherein the mucoadhesive layer is buffered to a pH of about 4.75 and the backing layer is buffered to a pH of about 4.25.

6. The device according to claim 1 wherein the bioavailability of buprenorphine absorbed from the device is greater than 40%.

7. The device according to claim 1 , wherein the at least one water-erodible polymer is selected from the group consisting of: polyacrylic acid (PAA), sodium carboxymethyl cellulose (NaCMC), hydroxypropylmethyl cellulose (HPMC), polyvinylpyrrolidone (PVP), hydroxyethylmethyl cellulose (HEMC), hydroxyethyl cellulose (HEC), hydroxypropyl cellulose (HPC), polyvinyl alcohol (PVA), polyethylene glycol (PEG), polyethylene oxide (PEO), and ethylene oxide-propylene oxide co-polymers.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Dec 23, 2025
From: BIOPHARMA CREDIT PLC
To: BIODELIVERY SCIENCES INTERNATIONAL, INC.
Reel/Frame 073308/0246 →
SECURITY INTEREST Recorded Dec 23, 2025
From: COLLEGIUM PHARMACEUTICAL, INC.; BIODELIVERY SCIENCES INTERNATIONAL, INC.; IRONSHORE PHARMACEUTICALS & DEVELOPMENT, INC.
To: TRUIST BANK, A NORTH CAROLINA CHARTERED BANK
Reel/Frame 073302/0334 →
SECURITY INTEREST Recorded Mar 22, 2022
From: BIODELIVERY SCIENCES INTERNATIONAL, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 059340/0176 →
RELEASE OF SECURITY INTEREST Recorded Mar 22, 2022
From: BPCR LIMITED PARTNERSHIP
To: BIODELIVERY SCIENCES INTERNATIONAL, INC.
Reel/Frame 059344/0733 →
PATENT AND TRADEMARK SECURITY AGREEMENTS TERMINATION Recorded May 30, 2019
From: CRG SERVICING LLC, AS ADMINISTRATIVE AGENT
To: BIODELIVERY SCIENCES INTERNATIONAL, INC.
Reel/Frame 049374/0336 →
SECURITY INTEREST Recorded Feb 24, 2017
From: BIODELIVERY SCIENCES INTERNATIONAL, INC.
To: CRG SERVICING LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 041370/0891 →
RELEASE OF SECURITY INTEREST Recorded Feb 22, 2017
From: MIDCAP FINANCIAL TRUST, AS SUCCESSOR AGENT TO MIDCAP FINANCIAL SBIC, LP
To: BIODELIVERY SCIENCES INTERNATIONAL, INC.; ARIUS TWO, INC.
Reel/Frame 041347/0940 →
SECURITY AGREEMENT Recorded Jul 8, 2013
From: BIODELIVERY SCIENCES INTERNATIONAL, INC.; ARIUS TWO, INC.
To: MIDCAP FINANCIAL SBIC, LP
Reel/Frame 030763/0336 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER PREVIOUSLY RECORDED ON REEL 029375 FRAME 0695. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 30, 2012
From: FINN, ANDREW; VASISHT, NIRAJ
To: BIODELIVERY SCIENCES INTERNATIONAL, INC.
Reel/Frame 029388/0845 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2012
From: FINN, ANDREW; VASISHT, NIRAJ
To: BIODELIVERY SCIENCES INTERNATIONAL, INC.
Reel/Frame 029375/0695 →